RecruitingNot applicableNCT07415720

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Principal Investigator
Sonia García-Calzón, PhD
University of Navarra
Intervention
Artichoke by-product capsules(dietary_supplement)
Enrollment
150 target
Eligibility
18-75 years · All sexes
Timeline
20262027

Study locations (1)

Collaborators

University of Navarra · Hospital of Navarra

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07415720 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials